Seneca Biopharma, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Rockville MD United States (1996)
Status: Acquired by Leading BioSciences, Inc (2021)

Organization Overview

First Clinical Trial
2011
NCT01310881
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Mergers & Acquisitions

Historical Acquisition Tree